71 results
Page 2 of 4
8-K
EX-10.1
8tcomjbk
19 Nov 21
Entry into a Material Definitive Agreement
6:08am
8-K
EX-10.1
upbrj2p3svlt50nh
29 Sep 21
U.S. FDA Approves LIVMARLI (maralixibat) as the First and Only Approved Medication for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome One Year of Age and Older
4:42pm
8-K
EX-10.1
dz7ke5 1lsqpqwidl1ol
27 Dec 19
Departure of Directors or Certain Officers
4:15pm
DRS
EX-10.15
vvy9ki9d2
27 Dec 19
Draft registration statement
12:00am
DRS
EX-10.9
2jiy3kwzyl 1qolo9fr
27 Dec 19
Draft registration statement
12:00am
S-1
EX-10.1
0cwnaqqm5jm
21 Jun 19
IPO registration
3:24pm